Feedback
DRREDDY 
Reputation: 642,681 • Aug 11, 2023 7:21 PM
Zydus Lifesciences Q1 Results: Profit more than doubles on US sales growth
Its U.S formulations business saw a revenue growth of 57.4% to 24.54 billion rupees, while India formulations grew by 9.1% to 12.27 billion rupees. India and U.S. sales make up 38% and 48% of Zydus' total revenue, respectively.
The Economic Times
Vote
Comment
Share
NSE:DRREDDY price when posted: 5,821.1